Persistent Fibroadipogenic Progenitor Expansion Following Transient DUX4 Expression Provokes a Profibrotic State in a

Darko Bosnakovski1,2, David Oyler1,2, Ana Mitanoska1,2

  • 1Lillehei Heart Institute, 312 Church St. SE, Minneapolis, MN 55455, USA.

Insights

Muscle regeneration after DUX4 gene expression is possible, but past DUX4 exposure leads to lasting fibrosis. This suggests long-term cellular changes in muscle tissue, impacting potential therapies for FSHD.

Area of Science:

  • Muscle biology
  • Regenerative medicine
  • Genetic disorders

Background:

  • Facioscapulohumeral muscular dystrophy (FSHD) is linked to DUX4 gene dysregulation.
  • DUX4 protein presence in FSHD muscle biopsies remains elusive, suggesting early expression events.
  • Understanding muscle regeneration after DUX4 insult is crucial for disease progression insights.

Purpose of the Study:

  • To investigate muscle regeneration capacity following DUX4-mediated degeneration.
  • To assess the long-term effects of DUX4 expression on muscle cellularity and fibrosis.
  • To explore the implications of these findings for FSHD therapeutic strategies.

Main Methods:

  • Utilized a mouse model (iDUX4pA;HSA) with inducible and reversible DUX4 expression.
  • Analyzed muscle histology and cytological parameters after controlled DUX4 expression periods.
  • Evaluated fibroadipogenic progenitor cell compartment and fibrosis propensity after DUX4 exposure and subsequent injury.

Main Results:

  • Muscle histology significantly recovered after DUX4 expression cessation, with recovery inversely proportional to expression duration.
  • The fibroadipogenic progenitor compartment remained elevated post-DUX4 expression, even after histological recovery.
  • Recovered muscle exhibited increased susceptibility to severe fibrosis upon secondary injury, indicating persistent pro-fibrotic alterations.

Conclusions:

  • Muscle can regenerate substantially from DUX4-induced damage, but not completely.
  • Past DUX4 expression induces lasting changes in muscle cellular physiology, promoting fibrosis.
  • These findings highlight the importance of addressing pro-fibrotic alterations in potential FSHD therapies.

Related Concept Videos